Low density lipoprotein cholesterol is predictable from vitamin D levels – meta-analysis March 2012

Influence of vitamin D supplementation on plasma lipid profiles: A meta-analysis of randomized controlled trials

Hao Wang, Ning Xia, Yang Yang and Dao-Quan Peng
Lipids in Health and Disease 2012, 11:42 doi:10.1186/1476-511X-11-42, Published: 20 March 2012
Abstract (provisional)  Download the PDF from Vitamin D Life

Observational studies have shown that low serum levels of vitamin D have been associated with an atherogenic lipid profile. However, the intervention studies gave divergent results. We conducted a meta-analysis of randomized controlled trials that evaluated the effects of vitamin D supplementation on blood lipids. A systematic literature search was conducted via MEDLINE, Cochrane library, and EMBASE for randomized controlled clinical trials assessing the effects of vitamin D supplementation on lipids. The mean change in total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C) and triglycerides (TG) from baseline was treated as a continuous variable. In all, 12 clinical trials consisting of 1346 participants were included in the analysis.

The pooled estimate of effect for vitamin D supplementation on LDL-C was 3.23 mg/dl (95% confidence interval, 0.55 to 5.90 mg/dl).

No statistically significant effects for vitamin D supplementation were observed for TC, HDL-C and TG (differences in means were 1.52 mg/dl (1.42 to 4.46 mg/dl), -0.14 mg/dl (0.99 to 0.71 mg/dl) and 1.92 mg/dl (7.72 to 3.88 mg/dl) respectively). The lipid modulating effects of vitamin D supplementation should be further investigated though large-scale, randomized trials with adequate doses which can effectively elevated the active form of vitamin D in plasma and with proper population which has hyperlipemia as an inclusion criterion.

---

See also Vitamin D Life

• Overview - Cholesterol and vitamin D
• All items tagged Cholesterol and Vitamin D 47 items